Related Experiment Video
Updated: Feb 6, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.8K
TGF-Beta Signaling in Bone with Chronic Kidney Disease
Yoshiko Iwasaki1, Hideyuki Yamato2, Masafumi Fukagawa3
1Department of Health Sciences, Oita University of Nursing and Health Sciences, Oita 870-1163, Japan. iwasaki@oita-nhs.ac.jp.
International Journal of Molecular Sciences
|August 15, 2018
Summary
Transforming growth factor-beta (TGF-β) is crucial for bone remodeling. In chronic kidney disease (CKD), TGF-β may mediate abnormal bone remodeling and ectopic calcification.
Area of Science:
- Bone biology
- Skeletal development
- Mineral metabolism
Background:
- Transforming growth factor-beta (TGF-β) signaling is vital for skeletal development and adult bone remodeling.
- Bone remodeling maintains skeletal homeostasis through balanced resorption and formation.
- Chronic kidney disease (CKD) disrupts mineral metabolism, leading to abnormal bone remodeling and ectopic calcification.
Purpose of the Study:
- To investigate the role of TGF-β in abnormal bone remodeling associated with CKD.
- To explore the involvement of TGF-β in the production and function of key humoral factors in CKD bone disease.
Main Methods:
- Literature review of studies on TGF-β, bone remodeling, and CKD.
- Analysis of the interplay between TGF-β and factors like PTH, FGF23, and Wnt inhibitors in CKD.
Main Results:
- TGF-β coordinates cellular activities during normal bone remodeling.
- Mineral metabolism disturbances in CKD alter bone remodeling and promote ectopic calcification.
- TGF-β is implicated in the production and actions of PTH, FGF23, and Wnt inhibitors in CKD.
Conclusions:
- TGF-β plays a significant role in maintaining bone homeostasis.
- Abnormal bone remodeling in CKD is linked to altered TGF-β signaling.
- TGF-β may act as a mediator of ectopic calcification in CKD.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
14.4K
11:06Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
11.1K
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
740
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
740
01:24Chronic Kidney Disease II: Clinical Manifestations
667
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
667
01:28Chronic Kidney Disease III: Interprofessional Care
479
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
479
01:18Chronic Kidney Disease IV: Nursing Management
400
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
400
01:16TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K